Increased atherosclerosis in mice with increased vascular biglycan content

Atherosclerosis

Volumn 235, Issue 1, 2014, Pages 71-75

  Thompson, Joel C ^a   Tang, Tao ^a   Wilson, Patricia G ^a   Yoder, Meghan H ^a   Tannock, Lisa R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Atherosclerosis; Biglycan; LDL retention; Mice

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIGLYCAN; GLYCOSAMINOGLYCAN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; SMOOTH MUSCLE ACTIN; TRIACYLGLYCEROL; ACTIN; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC VARIABILITY; HYPERLIPIDEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD VESSEL; C57BL MOUSE; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; TRANSGENE;

ACTINS; ANIMALS; ATHEROSCLEROSIS; BIGLYCAN; BLOOD VESSELS; DISEASE MODELS, ANIMAL; FEMALE; HYPERLIPIDEMIAS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; PROTEOGLYCANS; TRANSGENES;

EID: 84901833421     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.037     Document Type: Article

References (28)

1. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995, 15:551-561.
2. Huang F., Thompson J.C., Wilson P.G., et al. Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. JLipid Res 2008, 49:521-530.
3. Kunjathoor V.V., Chiu D.S., O'Brien K.D., et al. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 2002, 22:462-468.
4. Nakashima Y., Fujii H., Sumiyoshi S., et al. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007, 27:1159-1165.
5. O'Brien K.D., Olin K.L., Alpers C.E., et al. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: co-localization of biglycan with apolipoproteins. Circulation 1998, 98:519-527.
6. Skalen K., Gustafsson M., Rydberg E.K., et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002, 417:750-754.
7. Durante A., Peretto G., Laricchia A., et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Des 2012, 18:981-1004.
8. Shimizu-Hirota R., Sasamura H., Kuroda M., et al. Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration. Circ Res 2004, 94:1067-1074.
9. Tang T., Wilson P.G., Thompson J.C., et al. Prevention of TGFb induction attenuates angiotensinII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice. JLipid Res 2013, 54.
10. VanderLaan P.A., Reardon C.A., Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004, 24:12-22.
11. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007, 27:1248-1258.
12. Goldberg I.J., Eckel R.H., McPherson R. Triglycerides and heart disease: still a hypothesis?. Arterioscler Thromb Vasc Biol 2011, 31:1716-1725.
13. Hollmann J.A., Schmidt A., Von Bassewitz D.-B., et al. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and atherosclerotic human aortas. Arteriosclerosis 1989, 9:154-158.
14. Wasty F., Alavi M.Z., Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 1993, 36:316-322.
15. Figueroa J.E., Vijayagopal P. Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties. Atherosclerosis 2002, 162:261-268.
16. Schwenke D.C., Carew T.E. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. Arteriosclerosis 1989, 9:908-918.
17. Schwenke D.C., Carew T.E. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 1989, 9:895-907.
18. Frey H., Schroeder N., Manon-Jensen T., et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 2013, 280:2165-2179.
19. Kinsella M.G., Bressler S.L., Wight T.N. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 2004, 14:203-234.
20. Csont T., Gorbe A., Bereczki E., et al. Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. JMol Cell Cardiol 2010, 48:649-652.
21. Yang S.N., Burch M.L., Tannock L.R., et al. Transforming growth factor-beta regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes. JDiabetes 2010, 2:233-242.
22. Pfeiffer A., Middelberg-Bisping K., Drewes C., et al. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabetes Care 1996, 19:1113-1117.
23. Sharma K., Ziyadeh F.N., Alzahabi B., et al. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 1997, 46:854-859.
24. Wilson P.G., Thompson J.C., Webb N.R., et al. SAA, but not CRP, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. Am J Pathol 2008, 173:1902-1910.
25. Lee R.T., Yamamoto C., Feng Y., et al. Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. JBiol Chem 2001, 276:13847-13851.
26. Chang M.Y., Potter-Perigo S., Tsoi C., et al. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. JBiol Chem 2000, 275:4766-4773.
27. Olsson U., Bondjers G., Camejo G. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes 1999, 48:616-622.
28. Rodriguez-Lee M., Ostergren-Lunden G., Wallin B., et al. Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein. Arterioscler Thromb Vasc Biol 2006, 26:130-135.